AI Article Synopsis

  • - The study investigates MCPIP1, a protein linked to cell differentiation and tumor suppression, which is minimally understood in the context of cancer, specifically neuroblastoma, a common childhood cancer.
  • - Findings show that MCPIP1 is not expressed in primary neuroblastoma and enforcing its expression in neuroblastoma cells significantly reduces their growth and survival.
  • - The research reveals that overexpressed MCPIP1 decreases levels of the choline transporter (CTL1) and identifies microRNA-3613-3p as a key player, suggesting that MCPIP1 may regulate this microRNA, impacting choline transport in cancer cells.

Article Abstract

The recently discovered MCPIP1 (monocyte chemoattractant protein-induced protein 1), a multidomain protein encoded by the MCPIP1 (ZC3H12A) gene, has been described as a new differentiation factor, a ribonuclease, and a deubiquitination-supporting factor. However, its role in cancer is poorly recognized. Our recent analysis of microarrays data showed a lack of expression of the MCPIP1 transcript in primary neuroblastoma, the most common extracranial solid tumor in children. Additionally, enforced expression of the MCPIP1 gene in BE(2)-C cells caused a significant decrease in neuroblastoma proliferation and viability. Aim of the present study was to further investigate the role of MCPIP1 in neuroblastoma, using expression DNA microarrays and microRNA microarrays. Transient transfections of BE(2)-C cells were used for overexpression of either wild type of MCPIP1 (MCPIP1-wt) or its RN-ase defective mutant (MCPIP1-ΔPIN). We have analyzed changes of transcriptome and next, we have used qRT-PCR to verify mRNA levels of selected genes responding to MCPIP1 overexpression. Additionally, protein levels were determined for some of the selected genes. The choline transporter, CTL1, encoded by the SLC44A1 gene, was significantly repressed at the specific mRNA and protein levels and most importantly this translated into a decreased choline transport in MCPIP1-overexpressing cells. Then, we have found microRNA-3613-3p as the mostly altered in the pools of cells overexpressing the wild type MCPIP1. Next, we analyzed the predicted targets of the miR-3613-3p and validated them using qRT-PCR and western blot. These results indicate that the expression of miR-3613-3p might be regulated by MCPIP1 by cleavage of its precursor form.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.25354DOI Listing

Publication Analysis

Top Keywords

mcpip1
9
monocyte chemoattractant
8
chemoattractant protein-induced
8
protein-induced protein
8
expression mcpip1
8
be2-c cells
8
wild type
8
type mcpip1
8
selected genes
8
protein levels
8

Similar Publications

The endonuclease activity of MCPIP1 controls the neoplastic transformation of epithelial cells via the c-Met/CD44 axis.

Cell Commun Signal

January 2025

Department of General Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.

The RNase activity of MCPIP1 is essential for regulating cellular homeostasis, proliferation, and tumorigenesis. Our study elucidates the effects of downregulation of MCPIP1 expression and an RNase-inactivating mutation (D141N) on normal epithelial kidney cells, indicating that MCPIP1 expression is a key factor that suppresses neoplastic transformation. We observed that either expression downregulation or mutation of MCPIP1 significantly increased its clonogenicity and altered the expression of cancer stem cell (CSC) markers and factors involved in epithelial-to-mesenchymal transition (EMT).

View Article and Find Full Text PDF

Diosmetin alleviates TNFα-induced liver inflammation by improving liver sinusoidal endothelial cell dysfunction.

Biomed Pharmacother

January 2025

Jagiellonian University, Faculty of Biochemistry, Biophysics and Biotechnology, Department of General Biochemistry, Gronostajowa 7, Kraków 30-387, Poland. Electronic address:

Sterile inflammation contributes to the development of many liver diseases including non-alcoholic fatty liver disease. Tumor necrosis factor alpha (TNFα) is a key cytokine driving liver inflammation primarily through pro-inflammatory activation of liver sinusoidal endothelial cells (LSEC). The knowledge of whether modulating LSEC activation can alleviate liver inflammation is scarce.

View Article and Find Full Text PDF

Background: Liver sinusoidal endothelial cells (LSECs) have transcellular pores, called fenestrations, participating in the bidirectional transport between the vascular system and liver parenchyma. Fenestrated LSECs indicate a healthy phenotype of liver while loss of fenestrations (defenestration) in LSECs is associated with liver pathologies.

Methods: We introduce a unique model of systemic inflammation triggered by the deletion of Mcpip1 in myeloid leukocytes (Mcpip1LysM) characterised by progressive alterations in LSEC phenotype.

View Article and Find Full Text PDF

MCPIP1 modulates the miRNA‒mRNA landscape in keratinocyte carcinomas.

J Exp Clin Cancer Res

October 2024

Faculty of Biochemistry, Biophysics and Biotechnology, Department of General Biochemistry, Jagiellonian University, Gronostajowa 7, Krakow, 30-387, Poland.

Article Synopsis
  • MCPIP1 is a protein that helps control inflammation and may prevent tumors; mice lacking this protein are more prone to developing skin tumors from certain chemical exposures.
  • The study used advanced sequencing techniques to explore how MCPIP1 regulates specific microRNAs and their effect on gene expression in skin tumors induced by chemicals.
  • Findings revealed significant changes in gene expression with 2400 different protein-coding genes and 33 microRNAs affected, highlighting the direct impact of MCPIP1 on microRNA levels and its role in promoting skin cancer cell growth.
View Article and Find Full Text PDF

MCPIP1 Elicits a Therapeutic Effect on Cervical Cancer by Facilitating XIAP mRNA Decay via Its Endoribonuclease Activity.

Int J Mol Sci

September 2024

Hunan Provincial Key Laboratory of Medical Virology, Institute of Pathogen Biology and Immunology of College of Biology, Hunan University, Changsha 410082, China.

Article Synopsis
  • * Researchers have found that MCPIP1, a protein with specific domains, helps inhibit cervical cancer cell growth and promotes programmed cell death (apoptosis) by targeting a known inhibitor of apoptosis called XIAP.
  • * Targeted delivery of MCPIP1 in mice shows promising results by slowing down tumor growth, suggesting potential new strategies for treating cervical cancer in clinical settings.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!